Focal Therapeutics

About:

Focal Therapeutics develops novel tissue-marking devices for use in surgery designed to mark the surgical site of tissue removal in 3D.

Website: http://focalrx.com/

Twitter/X: focalrx

Top Investors: Okapi Venture Capital, Emergent Medical Partners

Description:

Focal Therapeutics is a medical device company that was established to help surgeons, radiation oncologists, and other clinicians to clearly identify a surgical site through the use of an innovative tissue marker. The company’s BioZorb™ tissue marker is an implantable device placed by surgeons that delineates the site of tissue removal in three dimensions. BioZorb is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up. Focal Therapeutics’ leadership team has a long track record in the development and commercialization of medical devices, particularly in the field of breast cancer care. As such, the company has chosen to offer BioZorb initially to surgeons and radiation oncologists who treat breast cancer patients.